Hatzis C - Search Results

1

Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden.

Qing T, Mohsen H, Marczyk M, Ye Y, O'Meara T, Zhao H, Townsend JP, Gerstein M, Hatzis C, Kluger Y, Pusztai L. Qing T, et al. Among authors: hatzis c. Nat Commun. 2020 May 15;11(1):2438. doi: 10.1038/s41467-020-16293-7. Nat Commun. 2020. PMID: 32415133 Free PMC article.

2

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.

Li X, Kumar S, Harmanci A, Li S, Kitchen RR, Zhang Y, Wali VB, Reddy SM, Woodward WA, Reuben JM, Rozowsky J, Hatzis C, Ueno NT, Krishnamurthy S, Pusztai L, Gerstein M. Li X, et al. Among authors: hatzis c. Genome Med. 2021 Apr 26;13(1):70. doi: 10.1186/s13073-021-00879-x. Genome Med. 2021. PMID: 33902690 Free PMC article.

3

Comprehensive Analysis of Metabolic Isozyme Targets in Cancer.

Marczyk M, Gunasekharan V, Casadevall D, Qing T, Foldi J, Sehgal R, Shan NL, Blenman KRM, O'Meara TA, Umlauf S, Surovtseva YV, Muthusamy V, Rinehart J, Perry RJ, Kibbey R, Hatzis C, Pusztai L. Marczyk M, et al. Among authors: hatzis c. Cancer Res. 2022 May 3;82(9):1698-1711. doi: 10.1158/0008-5472.CAN-21-3983. Cancer Res. 2022. PMID: 35247885 Free PMC article.

4

Reproducibility of research and preclinical validation: problems and solutions.

Pusztai L, Hatzis C, Andre F. Pusztai L, et al. Among authors: hatzis c. Nat Rev Clin Oncol. 2013 Dec;10(12):720-4. doi: 10.1038/nrclinonc.2013.171. Epub 2013 Oct 1. Nat Rev Clin Oncol. 2013. PMID: 24080600 Review.

5

Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations.

Patwardhan GA, Marczyk M, Wali VB, Stern DF, Pusztai L, Hatzis C. Patwardhan GA, et al. Among authors: hatzis c. NPJ Breast Cancer. 2021 May 26;7(1):60. doi: 10.1038/s41523-021-00270-4. NPJ Breast Cancer. 2021. PMID: 34040000 Free PMC article.

6

Functional germline variants as potential co-oncogenes.

Agarwal D, Nowak C, Zhang NR, Pusztai L, Hatzis C. Agarwal D, et al. Among authors: hatzis c. NPJ Breast Cancer. 2017 Nov 22;3:46. doi: 10.1038/s41523-017-0051-5. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 29177190 Free PMC article. Review.

7

Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.

O'Meara T, Safonov A, Casadevall D, Qing T, Silber A, Killelea B, Hatzis C, Pusztai L. O'Meara T, et al. Among authors: hatzis c. Breast Cancer Res Treat. 2019 May;175(1):247-259. doi: 10.1007/s10549-019-05156-5. Epub 2019 Feb 6. Breast Cancer Res Treat. 2019. PMID: 30725384 Free PMC article.

8

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells.

Marczyk M, Patwardhan GA, Zhao J, Qu R, Li X, Wali VB, Gupta AK, Pillai MM, Kluger Y, Yan Q, Hatzis C, Pusztai L, Gunasekharan V. Marczyk M, et al. Among authors: hatzis c. Cancers (Basel). 2020 Sep 8;12(9):2551. doi: 10.3390/cancers12092551. Cancers (Basel). 2020. PMID: 32911681 Free PMC article.

9

Data augmentation based on waterfall plots to increase value of response data generated by small single arm Phase II trials.

Han G, Pusztai L, Hatzis C. Han G, et al. Among authors: hatzis c. Contemp Clin Trials. 2021 Nov;110:106589. doi: 10.1016/j.cct.2021.106589. Epub 2021 Oct 9. Contemp Clin Trials. 2021. PMID: 34634476 Clinical Trial.

10

Functional polymorphisms in cancer.

Agarwal D, Hatzis C, Pusztai L. Agarwal D, et al. Among authors: hatzis c. Oncoscience. 2015 Feb 20;2(2):73-4. doi: 10.18632/oncoscience.129. eCollection 2015. Oncoscience. 2015. PMID: 25859546 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters